FDA Investigator Myla D Chapman

Myla D Chapman has conducted inspections on 203 sites in 6 countries as of 05 Sep 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
203
Last Inspection Date:
05 Sep 2018
Investigator Role:
FDA Investigator
Redica ID:
100005172
Countries of Inspections:
United States of America, India, Italy, Russian Federation, Slovakia, France
FDA Investigators that have inspected at least one site in common with Myla D Chapman:
Adam J Williams, Ann B Borromeo, Anne E Johnson, Annette Melendez, April R Bowen, Babatunde D Babalola, Barbara T Carmichael, Bonita S Chester, Brandy D Brown, Carlos A Ortiz, CDR Rochelle B Young, RPh, MSA, Chateryl K Washington, Christopher M Jeffers, Claudele S Razo, Claudette D Brooks, Cordelia J Brammer, Dana M Klimavicz, David T Glover, Deborah A Greco, Dellarese L Herbert, Douglas Brogden B, Ernest H Blackwood, Esra Toussaint, Gabriel R Mclemore, Gamal A Norton, Gates E Raynor, Helen R Bester, Igbinoba, Ingrid A Zambrana, Jackie M Douglas, Janaysia N Trail, Janet B Gray, Jawaid Hamid, Jennifer C Adams, Jennifer C Johnson, Jessica Fields, John D Lloyd, Joseph F Owens, Kara D Dobbin, Karen L Anderson, Karen M Cooper, Kathryn A Nagy, Katrina B Mosley Sloan, Kellie R Riggs, Kenny R Robinson, Keri U Walker, Kimberly Cdelk Brooks, Lakisha N Morton, Lareese K Thomas, Lawrence S Newsom, Leah M Andrews, Leslie W Gilbert, Lorenzo Jones, Maridali Deleon Torres, Matthew G Brown, Matthew R Coleman, Megan K Robinson, Melanie W Pishnery, Miaja Umaedi, Michelle D Haamid, Michelle M Noe Varga, Myoshi M Francis, N'jere English, Nancy E Fontaine, Naveen B Walker, Nicole M Bell, Randy L Clarida, Richard L Garcia, Robert P Neligan, Robert Q Green, Sally Gopaul, Sandra C Lawrence, Sandra I Gaul, Sarah C Pichette, Sayeeda Hdabe, Sereen Gmorgan Murray, Sharna D Pratt, Shayla G Turnipseed, Sheri S Oliver, Sherry R Dunn, Stardust W Mazzariello, Stephanie E Hubbard, Stephanie Harrell, Theresa L Stewart, Traci M Armand, Trang N Cox, Vanessa E Coulter, Viviana Matta

Myla D Chapman's Documents

Publish Date Document Type Title
May, 2007 EIR Stewart, Lynette D. M.D. - EIR, 2007-05-18
December, 2008 EIR Salzberg, Bruce A. - EIR, 2008-12-08
June, 2001 EIR Michael D. Banov, MD - EIR, 2001-06-07
December, 2015 FDA 483 Benjamin D. Gold, M.D. - Form 483, 2015-12-22
March, 2001 EIR Nichols, John E. MD - EIR, 2001-03-02
October, 2000 EIR Carman, John S., M.D./Carman Research - EIR, 2000-10-26
November, 2011 FDA 483 Abbott Laboratories, Inc. - Form 483, 2011-11-30
April, 2002 FDA 483 Saleh, Mansoor N. M.D. - Form 483, 2002-04-15
December, 2002 FDA 483 Floyd Medical Center IRC - Form 483, 2002-12-18
December, 2015 EIR Benjamin D. Gold, M.D. - EIR, 2015-12-22
July, 2015 FDA 483 George Geils, Jr. M.D. - Form 483, 2015-07-22
April, 2002 EIR Saleh, Mansoor N. M.D. - EIR, 2002-04-15
April, 2002 FDA 483 Response Saleh, Mansoor N. M.D. - Form 483R, 2002-04-18
December, 2008 FDA 483 Salzberg, Bruce A. - Form 483, 2008-12-08
August, 2000 EIR Levy, Robyn, MD - EIR, 2000-08-23
July, 2002 EIR Kassabian, Vahan S. MD - EIR, 2002-07-03
February, 2001 EIR Paul B. Miller, MD - EIR, 2001-02-28
May, 2007 FDA 483 Stewart, Lynette D. M.D. - Form 483, 2007-05-18
December, 2004 FDA 483 St Joseph Hospital IRB - Form 483, 2004-12-08
May, 2001 EIR Bruce W. Bode, MD - EIR, 2001-05-09
April, 2014 EIR Tiffani K. Hamilton, M.d. - EIR, 2014-04-22
December, 2000 EIR Robert A. Riesenberg, M.D. - EIR, 2000-12-13
December, 2000 FDA 483 Atlanta Center for Medical Research - Form 483, 2000-12-13
March, 2015 EIR UCB Biosciences Inc. - EIR, 2015-03-19
May, 2001 EIR Bruce W. Bode, MD - EIR, 2001-05-09
May, 2000 EIR Douglas G. Day, MD - EIR, 2000-05-10
July, 2015 EIR George Geils, Jr. M.D. - EIR, 2015-07-22
February, 2014 EIR Emory University Hospital/Emory Eye Clinic - EIR, 2014-02-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more